Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
British Journal of Haematology
|
May 21, 2020
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy
Nicole A Carreau, Philippe Armand, Reid W Merryman, et al.
British Journal of Haematology
|
April 20, 2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network
Massimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Blood Advances
|
August 30, 2024
Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation
Narendranath Epperla, Ying Huang, Amanda F Cashen, et al.
British Journal of Haematology
|
November 5, 2019
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia
Toby A Eyre, Lindsey E Roeker, Christopher P Fox, et al.
Acta Haematologica
|
July 18, 2019
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
Frederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Cancer
|
January 30, 2019
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study
Steven I Park, Steven M Horwitz, Francine M Foss, et al.
Cancer
|
July 28, 2017
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy
Narendranath Epperla, Kami J Maddocks, Mohammed Salhab, et al.
Cancer
|
December 3, 2016
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States
Kenneth R Carson, Steven M Horwitz, Lauren C Pinter-Brown, et al.
American Journal of Hematology
|
November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies
Luciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
The Oncologist
|
July 29, 2020
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy
Nicole A Carreau, Orrin Pail, Philippe Armand, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
British Journal of Haematology
|
May 21, 2020
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy
Nicole A Carreau, Philippe Armand, Reid W Merryman, et al.
British Journal of Haematology
|
April 20, 2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network
Massimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Blood Advances
|
August 30, 2024
Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantation
Narendranath Epperla, Ying Huang, Amanda F Cashen, et al.
British Journal of Haematology
|
November 5, 2019
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia
Toby A Eyre, Lindsey E Roeker, Christopher P Fox, et al.
Acta Haematologica
|
July 18, 2019
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
Frederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Cancer
|
January 30, 2019
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study
Steven I Park, Steven M Horwitz, Francine M Foss, et al.
Cancer
|
July 28, 2017
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy
Narendranath Epperla, Kami J Maddocks, Mohammed Salhab, et al.
Cancer
|
December 3, 2016
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States
Kenneth R Carson, Steven M Horwitz, Lauren C Pinter-Brown, et al.
American Journal of Hematology
|
November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies
Luciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
The Oncologist
|
July 29, 2020
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy
Nicole A Carreau, Orrin Pail, Philippe Armand, et al.
Page
of 9